My Treatment Approach: Interpreting the Data for Early-Stage HR+ Breast Cancer

In this series, we will discuss recent advances in the treatment of HR+ breast cancer. We will review two patient cases and discuss our treatment approach to illustrate how we are incorporating recent trial data into our clinical practice.

EP. 1: Clinical Case 1: High-Risk Early-Stage HR+ Breast Cancer

June 29th 2023

Stephanie Graff, MD, presents a clinical case of a patient who is diagnosed with HR+ early-stage breast cancer.

EP. 2: Risk Factors and the Treatment Plan

June 29th 2023

Rachel Layman, MD, describes her impression of the case and discusses risk assessment and a treatment plan for the patient.

EP. 3: Endocrine Therapy for Early-Stage Breast Cancer

July 6th 2023

Expert medical oncologists provide an overview of current endocrine therapy approved for early-stage breast cancer.

EP. 4: Key Findings from the monarchE Trial

July 6th 2023

Stephanie Graff, MD, and Rachel Layman, MD, discuss the design and results of the monarchE trial, which evaluated abemaciclib plus endocrine therapy for HR+, HER2 negative, node positive, high-risk early breast cancer.

EP. 5: Individualizing Care with CDK 4/6 Inhibitors

July 13th 2023

Stephanie Graff, MD, and Rachel Layman, MD, discuss how to individualize care with CDK4/6 inhibitors in patients with high-risk early breast cancer.

EP. 6: Age-Dependent Results With CDK 4/6 Inhibitors

July 13th 2023

Experts in breast oncology review age-dependent outcomes with CDK 4/6 inhibitors.

EP. 7: Dosing CDK 4/6 Inhibitors

July 20th 2023

Rachel Layman, MD, summarizes how to dose CDK4/6 inhibitors in different clinical settings.

EP. 8: Implementing Trial Data to Our Practice

July 20th 2023

Stephanie Graff, MD, and Rachel Layman, MD, discuss how they would apply the results of the monarchE trial to clinical case scenarios.

EP. 9: Selecting Endocrine Therapy in BRCA1/BRCA2+ Breast Cancer

July 27th 2023

Experts in breast oncology discuss how they select endocrine therapy in BRCA1/BRCA2+ breast cancer.

EP. 10: Clinical Case 2: High-Risk Early-Stage HR+ Breast Cancer

July 27th 2023

Rachel Layman, MD, presents a clinical case of a patient who is diagnosed with HR+ early-stage breast cancer.